✦ LIBER ✦

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome

✍ Scribed by Jonathan Krell; Colin R. James; Deep Shah; Ondrej Gojis; Adrian Lim; Pippa Riddle; Riz Ahmad; Andreas Makris; Andrew Cowdray; Angela Chow; Tamerlan Babayev; Peter Madden; Robert Leonard; Susan Cleator; Carlo Palmieri

Book ID: 113538916
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 371 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Phase II Randomized Study of Trastuzumab

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

✍ Hurvitz, S. A.; Dirix, L.; Kocsis, J.; Bianchi, G. V.; Lu, J.; Vinholes, J.; Gua 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Use of adjuvant trastuzumab in women wit

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

✍ Rachel A. Freedman; Melissa E. Hughes; Rebecca A. Ottesen; Jane C. Weeks; Yulei 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Adding hormonal therapy to chemotherapy

Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

✍ Naoki Hayashi, Naoki Niikura, Hideko Yamauchi, Seigo Nakamura, Naoto T. Ueno 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 279 KB

Lapatinib: A small-molecule inhibitor of

Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer

✍ Amye J. Tevaarwerk; Jill M. Kolesar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Time to first tumor progression as a pre

Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer

✍ Mitsuhiro Hayashi; Yasuhiro Okumura; Tomofumi Osako; Yasuo Toyozumi; Nobuyuki Ar 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 215 KB